By Ethel Makila, Associate Director, Advocacy Policy and Communications, IAVI
Thumbi Ndung'u, Ph.D., provides a view of current strategies for HIV vaccine and cure design
IAVI recognizes the government of Japan’s continued commitment to HIV vaccine research and most recently COVID-19 vaccine research and applauds ...
Findings offer promise for accelerated development of antibody-based prevention and treatment for COVID-19
Summarizing the impact of COVID-19 on ongoing HIV and TB prevention research
IAVI's response to the role that racism and systematic oppression play in the daily lives of black people
Mark Feinberg and Swati Gupta introduce viewers to the COVID-19 vaccine candidate, which uses the same technology as Merck’s Ebola ...
Seventh edition of webinar series tackles community engagement in a time of social distancing.
IAVI welcomes evidence of cabotegravir’s safety and efficacy in cisgender men and transgender women who have sex with men.
IAVI's response to the COVID-19 pandemic